TheAnswerPage

JANUARY 11, 2022

Since 2012, TheAnswerPage.com has addressed the immense need for unbiased evidence-based high quality education focused on the endocannabinoid system and medical marijuana. Results of an observational study merely suggest an association between a therapeutic agent or an event and an outcome. Available at: [link] Accessed 05 Dec.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. She enjoyed commercial success in Latin America managing Merck’s Diversified Brands, including Bacillus Calmette–Guérin (BCG) in 2011 and 2012. Sesen Bio is currently in the follow-up stage of a Phase 3 registration trial in the US for the treatment of BCG-unresponsive NMIBC.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

FEBRUARY 28, 2020

The combination of experience, wisdom and the optimism of the recent entrants is positively intoxicating, and has created an exciting buzz at events, but there will be bumps along the road and we should expect teething problems. Events were full of people talking about how this technology would revolutionise everything.

Law 59

Law Research and Development Recreational Cannabis 59

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. years (Atakan 2012 ). The review, however, did not cover patient access to medicinal cannabis.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. in/rickdoblin/ [link]. Molly Maloof. Psychedelic News Hour. in/ingmargorman/ [link]. in/spencer-hawkswell-210a8189/ [link]. Noah Potter.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51